pyrimidin-2-one beta-ribofuranoside has been researched along with Innate Inflammatory Response in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| He, G; Li, H; Song, K; Tang, Y; Wang, Z; Xu, G; Xu, W; Yang, X; Yu, B; Zeng, X | 1 |
| Chung, S; Kim, HS; Kim, M; Kim, S; Kim, WY; Koh, ES; Park, CW; Park, JY; Pyo, J; Shin, SJ; Son, M | 1 |
| Bible, PW; Ge, X; Hu, X; Lee, RWJ; Li, JJ; Li, Y; Liu, Y; Miao, L; Schewitz-Bowers, LP; Stimpson, M; Wei, L; Wen, X; Yang, L; Zou, Y | 1 |
3 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Innate Inflammatory Response
| Article | Year |
|---|---|
Zebularine protects against blood-brain-barrier (BBB) disruption through increasing the expression of zona occludens-1 (ZO-1) and vascular endothelial (VE)-cadherin.
Topics: AMP-Activated Protein Kinases; Animals; Blood-Brain Barrier; Cadherins; Cytidine; Endothelium, Vascular; Inflammation; Mice; Protective Agents; Stroke; Zonula Occludens-1 Protein | 2022 |
The Protective Effect of Zebularine, an Inhibitor of DNA Methyltransferase, on Renal Tubulointerstitial Inflammation and Fibrosis.
Topics: Animals; DNA; DNA Modification Methylases; Fibrosis; Inflammation; Mice; Nephritis; Renal Insufficiency, Chronic; Ureteral Obstruction | 2022 |
The DNA Methylation Inhibitor Zebularine Controls CD4
Topics: Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Cells, Cultured; Cytidine; DNA Methylation; Female; Forkhead Transcription Factors; Humans; Inflammation; Interferon-gamma; Interleukin-17; Mice; Mice, Inbred C57BL; Principal Component Analysis; Uveitis | 2019 |